封面
市场调查报告书
商品编码
1412679

吸入麻醉剂市场:按类型、最终用途划分 - 2024-2030 年全球预测

Inhalation Anesthetics Market by Type (Desfluran, Isoflurane, Sevoflurane), End Use (Ambulatory Surgical Centers, Hospitals) - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年吸入麻醉剂市场规模为16.8亿美元,预计2024年将达18.5亿美元,2030年将达35.9亿美元,复合年增长率为11.44%。

全球吸入麻醉剂市场

主要市场统计
基准年[2023] 16.8亿美元
预测年份 [2024] 18.5亿美元
预测年份 [2030] 35.9亿美元
复合年增长率(%) 11.44%
吸入麻醉药市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估吸入麻醉剂市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以对吸入麻醉剂市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略,从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解:

1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。

3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1-吸入麻醉剂市场的市场规模与预测是多少?

2-在吸入麻醉剂市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些?

3-吸入麻醉剂市场的技术趋势和法律规范是什么?

4-吸入麻醉剂市场主要供应商的市场占有率为何?

5-进入吸入麻醉剂市场的适当型态和策略性手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 外科手术数量增加
      • 改善获得医疗服务和手术的机会
    • 抑制因素
      • 减少与医疗保健相关的温室气体排放
    • 机会
      • 密集推出新型吸入麻醉解决方案
    • 任务
      • 吸入麻醉剂的副作用
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章吸入麻醉剂市场:依类型

  • DESFLURANE
  • Isoflurane
  • SEVOFLURANE

第七章吸入麻醉剂市场:依最终用途

  • 门诊手术中心
  • 医院

第八章美洲吸入麻醉剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太吸入麻醉剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲吸入麻醉剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析:按主要企业划分
  • 主要企业竞争情境分析

第12章竞争产品组合

  • 主要公司简介
    • AbbVie Inc.
    • Baxter International Inc.
    • Dechra Pharmaceuticals PLC
    • Eisai Co., Ltd.
    • Fresenius SE & Co. KGaA
    • Halocarbon Life Sciences, LLC
    • Hikma Pharmaceuticals PLC
    • Jiangsu Hengrui Medicine Co. Ltd.
    • Kent Scientific Corporation
    • Lunan Pharmaceutical Group Co. Ltd.
    • Midmark Corporation
    • Piramal Enterprises Limited
    • Raman & Weil Pvt. Ltd.
    • Sandoz International GmbH
    • Troikaa Pharmaceuticals Limited
  • 主要产品系列

第十三章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-742BD517FC6C

[194 Pages Report] The Inhalation Anesthetics Market size was estimated at USD 1.68 billion in 2023 and expected to reach USD 1.85 billion in 2024, at a CAGR 11.44% to reach USD 3.59 billion by 2030.

Global Inhalation Anesthetics Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.68 billion
Estimated Year [2024] USD 1.85 billion
Forecast Year [2030] USD 3.59 billion
CAGR (%) 11.44%
Inhalation Anesthetics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhalation Anesthetics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhalation Anesthetics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Inhalation Anesthetics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Baxter International Inc., Dechra Pharmaceuticals PLC, Eisai Co., Ltd., Fresenius SE & Co. KGaA, Halocarbon Life Sciences, LLC, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co. Ltd., Kent Scientific Corporation, Lunan Pharmaceutical Group Co. Ltd., Midmark Corporation, Piramal Enterprises Limited, Raman & Weil Pvt. Ltd., Sandoz International GmbH, and Troikaa Pharmaceuticals Limited.

Market Segmentation & Coverage

This research report categorizes the Inhalation Anesthetics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Desfluran
    • Isoflurane
    • Sevoflurane
  • End Use
    • Ambulatory Surgical Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Inhalation Anesthetics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhalation Anesthetics Market?

3. What are the technology trends and regulatory frameworks in the Inhalation Anesthetics Market?

4. What is the market share of the leading vendors in the Inhalation Anesthetics Market?

5. Which modes and strategic moves are suitable for entering the Inhalation Anesthetics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Inhalation Anesthetics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of surgical procedures
      • 5.1.1.2. Increasing Accessibility to Health Services and Surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Contributor to health care-related greenhouse gas emissions
    • 5.1.3. Opportunities
      • 5.1.3.1. Intense launch of the new inhalation anesthesia solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Side-effects of inhaler anesthesia drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Inhalation Anesthetics Market, by Type

  • 6.1. Introduction
  • 6.2. Desfluran
  • 6.3. Isoflurane
  • 6.4. Sevoflurane

7. Inhalation Anesthetics Market, by End Use

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals

8. Americas Inhalation Anesthetics Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Inhalation Anesthetics Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Inhalation Anesthetics Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. AbbVie Inc.
    • 12.1.2. Baxter International Inc.
    • 12.1.3. Dechra Pharmaceuticals PLC
    • 12.1.4. Eisai Co., Ltd.
    • 12.1.5. Fresenius SE & Co. KGaA
    • 12.1.6. Halocarbon Life Sciences, LLC
    • 12.1.7. Hikma Pharmaceuticals PLC
    • 12.1.8. Jiangsu Hengrui Medicine Co. Ltd.
    • 12.1.9. Kent Scientific Corporation
    • 12.1.10. Lunan Pharmaceutical Group Co. Ltd.
    • 12.1.11. Midmark Corporation
    • 12.1.12. Piramal Enterprises Limited
    • 12.1.13. Raman & Weil Pvt. Ltd.
    • 12.1.14. Sandoz International GmbH
    • 12.1.15. Troikaa Pharmaceuticals Limited
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. INHALATION ANESTHETICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INHALATION ANESTHETICS MARKET DYNAMICS
  • FIGURE 7. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 10. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. INHALATION ANESTHETICS MARKET SIZE, BY DESFLURAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 10. INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 99. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. INHALATION ANESTHETICS MARKET LICENSE & PRICING